Identification of the Unique Clinical and Genetic Features of Chinese Lung Cancer Patients With EGFR Germline Mutations in a Large-Scale Retrospective Study

Lung cancer in never smokers: The role of different risk factors other than tobacco smoking

(2020) Luis Corrales et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility

(2020) Mengyuan Liu et al.   Translational Lung Cancer Research

EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer

(2019) Shun Lu et al.   Journal of Thoracic Oncology

Population-based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer

(2019) Lisa A. Cannon-Albright et al.   Journal of Thoracic Oncology

Characteristics of Familial Lung Cancer in Yunnan-Guizhou Plateau of China

(2018) Xiaojie Ding et al.   Frontiers in Oncology

Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma

(2017) Erin M. Parry et al.   Journal of Thoracic Oncology

Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes

(2017) James D McKay et al.   NATURE GENETICS

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

High-throughput Phenotyping of Lung Cancer Somatic Mutations

(2016) Alice H. Berger et al.   CANCER CELL

Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations

(2016) Barbara Klughammer et al.   Journal of Thoracic Oncology

Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population

(2016) Krista A. Zanetti et al.   LUNG CANCER

Low-Frequency Coding Variants at 6p21.33 and 20q11.21 Are Associated with Lung Cancer Risk in Chinese Populations

(2015) Guangfu Jin et al.   AMERICAN JOURNAL OF HUMAN GENETICS

A family history of cancer and lung cancer risk in never-smokers: A clinic-based case–control study

(2015) Huan Lin et al.   LUNG CANCER

Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors

(2014) Hyun Sun Woo et al.   INVESTIGATIONAL NEW DRUGS

A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

(2014) Yuankai Shi et al.   Journal of Thoracic Oncology

Two Rare Exon 21 EGFR Mutations in Patients Treated with Gefitinib

(2013) Elisabet Mompradé et al.   Journal of Thoracic Oncology

Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors

(2012) Susumu Kobayashi et al.   Journal of Thoracic Oncology

Family history of lung cancer in never smokers with non-small-cell lung cancer and its association with tumors harboring EGFR mutations

(2012) Elizabeth M. Gaughan et al.   LUNG CANCER

Inherited Germline T790M Mutation and Somatic Epidermal Growth Factor Receptor Mutations in Non-small Cell Lung Cancer Patients

(2011) Carmelo Tibaldi et al.   Journal of Thoracic Oncology

Mutations of the epidermal growth factor receptor gene in NSCLC patients

(2011) BING HAN et al.   Oncology Letters

Analysis of Genetic Variants in Never-Smokers with Lung Cancer Facilitated by an Internet-Based Blood Collection Protocol: A Preliminary Report

(2010) N. Girard et al.   CLINICAL CANCER RESEARCH

Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma

(2010) Jason M Foster et al.   World Journal of Surgical Oncology

Good Response to Gefitinib in Lung Adenocarcinoma of Complex Epidermal Growth Factor Receptor (EGFR) Mutations with the Classical Mutation Pattern

(2008) S.-G. Wu et al.   ONCOLOGIST